Boditech Med Inc. (KOSDAQ:206640)

Market Cap	374.79B
Revenue (ttm)	138.16B
Net Income (ttm)	27.26B
Shares Out	21.79M
EPS (ttm)	1,242.00
PE Ratio	13.85
Forward PE	10.66
Dividend	150.00 (0.92%)
Ex-Dividend Date	Mar 31, 2025

Volume	189,118
Average Volume	92,158
Open	16,150
Previous Close	16,330
Day's Range	16,150 - 17,340
52-Week Range	13,350 - 21,050
Beta	0.26
RSI	64.30
Earnings Date	May 12, 2025

About Boditech Med

Boditech Med Inc. offers instruments and diagnostic reagents in South Korea and internationally. The company offers instruments, including ichroma II, diagnostic immuno-analyzer to measure the presence of various biomarkers for cardiac, cancer, hormones, infectious diseases, autoimmune diseases, and metabolic diseases; ichroma III, a high-throughput immuno-analyzer that enables simultaneous testing for various parameters; ExAmplar, a compact real time PCR that detects virus/bacteria quantitatively or qualitatively using ready-to-use cartridges;...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1998
• Employees: 491
• Stock Exchange: KOSDAQ
• Ticker Symbol: 206640

Financial Performance

In 2024, Boditech Med's revenue was 138.16 billion, an increase of 2.94% compared to the previous year's 134.22 billion. Earnings were 27.26 billion, an increase of 5.06%.